Age-related diminished ovarian reserve may be improved by stem cell-derived exosomes, an innovative bioactive treatment now being studied in primary ovarian insufficiency, which elevates Nrf2 and GPX4 expression while mitigating iron overload [83]. Here, NFE2L2 is linked to ovarian dysfunction.